Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rubella (German Measles) - Overview
Rubella (German Measles) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Rubella (German Measles) - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Rubella (German Measles) - Companies Involved in Therapeutics Development
Amogen Pharma Pvt Ltd
Beijing Minhai Biotechnology Co Ltd
Daiichi Sankyo Co Ltd
Enesi Pharma Ltd
Indian Immunologicals Ltd
Micron Biomedical Inc
Sinovac Biotech Ltd
Vaxxas Inc
Zhongyianke Biotech Co Ltd
Zydus Lifesciences Ltd
Rubella (German Measles) - Drug Profiles
(measles + mumps + rubella + varicella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + mumps + rubella + varicella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
(measles [strain Edmonstons-Zagreb] + rubella [strain RA-27]) vaccine - Drug Profile
Product Description
Mechanism Of Action
BK-1601 - Drug Profile
Product Description
Mechanism Of Action
rubella vaccine - Drug Profile
Product Description
Mechanism Of Action
VN-0102 - Drug Profile
Product Description
Mechanism Of Action
Rubella (German Measles) - Dormant Projects
Rubella (German Measles) - Product Development Milestones
Featured News & Press Releases
May 05, 2021: Enesi Pharma achieves key milestone in development of thermostable solid-dose live vaccines against measles and rubella
Mar 18, 2020: Vaxxas awarded US$5 million grant for clinical study of measles and rubella vaccition
Nov 30, 2019: Vaxxas was awarded research and development fund of USD 4,997,693 from Bill & Melinda Gates Foundation
Nov 30, 2016: Vaxxas was awarded research and development fund of USD 4,479,552 from Bill & Melinda Gates Foundation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Rubella (German Measles), 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Rubella (German Measles), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Rubella (German Measles) - Pipeline by Amogen Pharma Pvt Ltd, 2022
Rubella (German Measles) - Pipeline by Beijing Minhai Biotechnology Co Ltd, 2022
Rubella (German Measles) - Pipeline by Daiichi Sankyo Co Ltd, 2022
Rubella (German Measles) - Pipeline by Enesi Pharma Ltd, 2022
Rubella (German Measles) - Pipeline by Indian Immunologicals Ltd, 2022
Rubella (German Measles) - Pipeline by Micron Biomedical Inc, 2022
Rubella (German Measles) - Pipeline by Sinovac Biotech Ltd, 2022
Rubella (German Measles) - Pipeline by Vaxxas Inc, 2022
Rubella (German Measles) - Pipeline by Zhongyianke Biotech Co Ltd, 2022
Rubella (German Measles) - Pipeline by Zydus Lifesciences Ltd, 2022
Rubella (German Measles) - Dormant Projects, 2022